James Gordon

Stock Analyst at JP Morgan

(1.83)
# 1504
Out of 5,441 analysts
14
Total ratings
Success rate
Average return
7 Stocks
Name Action PT Current % Upside Ratings Updated
ARGX argenx
Maintains: Overweight
775 830
638.76 29.94% 6 Aug 4, 2025
GRFS Grifols
Maintains: Neutral
8 11
10.61 -2.92% 1 Jun 17, 2025
GMAB Genmab
Downgrades: Neutral
n/a
n/a n/a 1 Aug 20, 2024
MOR MorphoSys
Downgrades: Neutral
32 24
18.96 26.58% 2 Jun 11, 2021
FGEN FibroGen
Upgrades: Neutral
n/a
n/a n/a 1 Apr 7, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Neutral
n/a
n/a n/a 1 Jul 8, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
200 150
n/a n/a 2 Feb 20, 2018